Concepedia

A clinical trial assessing the safety and efficacy of taranabant, a CB1R inverse agonist, in obese and overweight patients: a high-dose study

Louis J. Aronne, Serena Tonstad, Manuel Moreno, Ira Gantz, Ngozi Erondu, S Suryawanshi, Cliona Molony, Solveig K. Sieberts, J. Nayee, A G Meehan,

International Journal of Obesity · 2010 · 88 citations · 39 references

DOI

Concepts

References

39

The PHQ-9

Kurt Kroenke, Robert L. Spitzer, Janet B. W. Williams · Journal of General Internal Medicine · 2001 · 44.2K citations · Full text

Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

Scott M. Grundy · JAMA · 1993 · 27.9K citations

, , +12

Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)

Evaluation Expert Panel on Detection · JAMA · 2001 · 26K citations

, , +10

Validation and Utility of a Self-report Version of PRIME-MD<SUBTITLE>The PHQ Primary Care Study</SUBTITLE>

Robert L. Spitzer · JAMA · 1999 · 9.8K citations

, , +17

The metabolic syndrome—a new worldwide definition

K. G. M. M. Alberti, Paul Zimmet, Jonathan E. Shaw · The Lancet · 2005 · 9.3K citations

, , +14